Fulvestrant Injection

Fulvestrant Injection

1 USD ($)/Box

Product Details:

  • Salt Composition Fulvestrant 250 mg per 5 ml (I.M. Injection)
  • Dosage Form Injection
  • Indication Hormone receptor-positive metastatic breast cancer in postmenopausal women
  • Enzyme Types Other
  • Feature Other
  • Ingredients Other
  • Application Other
  • Click to View more
X

Fulvestrant Injection Price And Quantity

  • 100 Box
  • 1 USD ($)/Box

Fulvestrant Injection Product Specifications

  • Other
  • Store at cool and dry place.
  • Hormone receptor-positive metastatic breast cancer in postmenopausal women
  • Other
  • Fulvestrant 250 mg per 5 ml (I.M. Injection)
  • Injection
  • Other
  • 2 Years
  • Normal Smell
  • Other
  • Clear, colorless to yellow, viscous solution
  • Prescription
  • For use by healthcare professional only
  • Known hypersensitivity to Fulvestrant or excipients; Pregnancy and lactation
  • Compatible with standard intramuscular injection protocols
  • 250 mg per 5 ml
  • Prefilled glass syringe with safety needle
  • Intramuscular (I.M.)
  • Rx Only, prescription medicine
  • 5 ml prefilled syringe
  • Recommended schedule: 250 mg every month or as directed by physician

Fulvestrant Injection Trade Information

  • surat
  • Cash Against Delivery (CAD), Cash on Delivery (COD), Cash Advance (CA), Letter of Credit (L/C), Telegraphic Transfer (T/T), Paypal, Western Union, Letter of Credit at Sight (Sight L/C), Delivery Point (DP), Days after Acceptance (DA), Cash in Advance (CID), Cheque
  • 1000000 Box Per Month
  • 4 Days
  • Contact us for information regarding our sample policy
  • 5 ml
  • Asia, Australia, North America, South America, Eastern Europe, Western Europe, Middle East, Africa, Central America
  • Dadra and Nagar Haveli, Nagaland, Uttarakhand, Daman and Diu, Lakshadweep, South India, East India, Andaman and Nicobar Islands, Assam, Arunachal Pradesh, Chandigarh, Delhi, Goa, Haryana, Himachal Pradesh, Jammu and Kashmir, Kerala, Madhya Pradesh, Maharashtra, Mizoram, Meghalaya, Manipur, Punjab, Pondicherry, Rajasthan, Sikkim, Tamil Nadu, Telangana, Tripura, West Bengal, Gujarat, Karnataka, North India, Bihar, Andhra Pradesh, Central India, Odisha, Jharkhand, West India, Chhattisgarh, Uttar Pradesh, All India
  • ISO/GMP/c-GMP/WHOGMP/USFDA/EUGMP.

Product Description

Since last manyyears SaintroyLifescienceis leading manufacture, export and supplierofFulvestrant Injectionfrom Surat, Gujarat, India. Fulvestrant Injection used for the treatment of hormone receptor positive metastatic breast cancer or locally advanced unresectable disease in postmenopausal women; it is given by injection.

Tags: Fulvestrant Injection manufacturer, Fulvestrant Injection exporter,Fulvestrant Injection supplier, and Fulvestrant Injection, whogmp approved Fulvestrant Injectionmanufacturer and supplier, Fulvestrant Injection distributor, Fulvestrant Injectionshipper, Fulvestrant Injection 5 ml Fulvestrant Injection 5mlsupplier,Fulvestrant Injection 5 ml.

ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturingfacility in Gujarat, India.

Registration: Saintroy Lifescienceis interested inregistration of own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTorCTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.

Export Country:Saintroy Lifescience Fulvestrant Injectionexport to USA, Canada, Germany, Europe, France, Ghana, Nigeria,Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile,Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia, HongKong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.



Precise Dosage and Administration

Each 5 ml prefilled syringe contains 250 mg of fulvestrant, designed for monthly intramuscular injections as per physician directives. The prefilled presentation with a safety needle ensures accurate dosing and reduces handling risk, making it suitable for use in healthcare facilities.


Therapeutic Indication and Benefit

Fulvestrant Injection is indicated for postmenopausal women with hormone receptor-positive metastatic breast cancer. Its mechanism targets estrogen receptors, providing a valuable treatment option in advanced cases where hormonal therapy is required.


Safety and Regulatory Compliance

This preparation is available strictly on prescription and is for use only by healthcare professionals. Contraindications include hypersensitivity to fulvestrant or its excipients, as well as pregnancy and lactation. Regulatory controls ensure patient safety and quality.


Storage and Stability

The injection must be stored in a cool, dry environment, away from direct sunlight, to maintain potency and safety. With a shelf life of up to two years, its stable formulation ensures efficacy throughout its intended use period.

FAQ's of Fulvestrant Injection:


Q: How should Fulvestrant Injection be administered and who is authorized to give it?

A: Fulvestrant Injection must be administered by a qualified healthcare professional via intramuscular injection, typically in the gluteal muscle. Patients should not attempt self-administration.

Q: What is the typical dosage and recommended administration schedule for this injection?

A: The recommended dosage is 250 mg (one 5 ml syringe) administered once a month, or as directed by a physician, following standard protocols for intramuscular injections.

Q: What is the primary medical use of Fulvestrant Injection?

A: This injection is used in postmenopausal women for the treatment of hormone receptor-positive metastatic breast cancer, helping to combat cancer growth dependent on estrogen receptors.

Q: Are there any specific contraindications or precautions associated with this medication?

A: Fulvestrant Injection is contraindicated in individuals with known hypersensitivity to fulvestrant or its excipients, and should not be used during pregnancy or lactation. It is for use by healthcare professionals only.

Q: Where should Fulvestrant Injection be stored to ensure quality?

A: The product should be kept in a cool, dry place to maintain its stability and efficacy, away from sunlight and moisture. Proper storage helps prevent degradation of the medication.

Q: What are the benefits of using a prefilled syringe with a safety needle for this product?

A: The prefilled glass syringe with a safety needle offers dose accuracy, improved safety for healthcare providers, and ease of use, reducing the risk of contamination or dosing errors.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anticancer Injection' category



Back to top